NatSpears Ltd.

www.natspears.com

High-Tech Company

Ceased to Operate Q3/2006

Graduated from: RAD BioMed

TECH VERTICALS

Biotechnology, Life Sciences, MedTech, Therapeutics

General Data

Sector	Biomed
Company Stage:	R&D
Established	2002
Number of Employees	2
Reg. Number:	abCDe

DESCRIPTION

NatSpears developed novel therapeutic compounds and diagnostic tools for the treatment of cancer and viral diseases, using its proprietary targeting & killing platform technology. NatSpears products were based on novel molecules capable of binding selectively to broad spectrum of tumor cells and viral infected cells and inducing their killing via natural mechanisms of the immune system. NatSpears compounds could have been used as therapeutic compounds by themselves or as a platform to improve efficacy and safety of chemotherapy agents.

TECHNOLOGY

NatSpears’ products were based on novel molecules capable of: Binding selectively to broad spectrum of tumor cells and viral infected cells. Inducing killing via natural mechanisms of the immune system.

Can be used as therapeutic compounds by themselves or as a platform to improve efficacy and safety of chemotherapy agents.

The company has demonstrated significant selectivity binding in vitro and preliminary promising results in vivo.

Extensive experiments in mice are being done to demonstrate the therapeutic potential for human melanoma and prostate cancer.

	TARGET MARKETS
	Hospitals, Medical Institutions.

	BUSINESS MODEL
	B2B

CONTACT INFO

Expand / Collapse All

Main Address: Ramat Gan, Israel

Address	2a Katzir St.
City	Ramat Gan
Country	Israel
Zip	52656

Contact Person	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title
Prof. Ofer Mandelboim	Co-Founder
Prof. Angel Porgador	Co-Founder

	FINANCIAL ROUNDS

Total Capital Raised
abCDe

Financial Rounds

Numbers of Investors

Expand / Collapse All

Round

Date

Stage

Amount

Valuation

Other

Oct. 22, 2002

abCDe

Seed

Oct. 22, 2002

Seed

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij*	Technology Transfer Company	abCDe	BGN received equity in the company in exchange for providing technology & IP.
abC Defghij	Government Agency	abCDe
abC Defghij	Incubator	abCDe
abC Defghij	Private Investor	abCDe
abC Defghij	Private Investor	abCDe

Last Updated:	abCDe
IVC Number:	abCDe